94762-2

LOINC 2.82

SARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay

SARS-CoV-2 Ab SerPl Ql IA

Definition

  • Qualitative detection of SARS-CoV-2 antibodies by an immunoassay method, such as an enzyme-linked immunosorbent assay or electrochemiluminescence immunoassay, in serum or plasma. This assay detects but does not differentiate between the antibody subtypes.

Component

  • SARS coronavirus 2 Ab

Specimen / system

  • Ser/Plas

Class

  • MICRO

Property

  • PrThr

Scale

  • Ord

Method

  • IA

Related names

  • 2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; SUDS; Viral Pneumonias; Wuhan coronavirus

Index terms

  • 2019 Novel Coronavirus
  • 2019-nCoV
  • ABS
  • Aby
  • Antby
  • Anti
  • Antibodies
  • Antibody
  • Autoantibodies
  • Autoantibody
  • Corona virus
  • COVID-19
  • COVID19
  • EIA
  • ELFA
  • ELISA
  • Enzyme immunoassay
  • IAA
  • ID
  • II
  • Infectious Disease
  • InfectiousDisease
  • MEIA
  • Microbiology
  • Ordinal
  • Pl
  • Plasma
  • Plsm
  • Point in time
  • PR
  • QL
  • Qual
  • Qualitative
  • Random
  • SARS Coronavirus 1
  • SARS coronavirus 2 Ab
  • SARS-CoV
  • SARS-CoV-1
  • SARS-CoV-2
  • Screen

10 further terms